Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Calcium/magnesium/potassium/sodium oxybates - Jazz Pharmaceuticals

Next Previous
X
Search
Drug Profile

Calcium/magnesium/potassium/sodium oxybates - Jazz Pharmaceuticals

Alternative Names: Calcium, magnesium, potassium, and sodium oxybates oral solution; JZP-258; Lower sodium oxybate; LXB; Oxybate mixed salt solution – Jazz Pharmaceuticals; Xywav

Latest Information Update: 12 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jazz Pharmaceuticals plc
  • Class Hydroxybutyrates; Sleep disorder therapies; Small molecules
  • Mechanism of Action Dopamine receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic hypersomnia; Narcolepsy
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cataplexy; Idiopathic hypersomnia; Narcolepsy

Most Recent Events

  • 13 Apr 2024 Efficacy data from a phase III trial in Idiopathic hypersomnia presented at the 76th Annual Meeting of the American Academy of Neurology 2024 (AAN-2024)
  • 10 Sep 2023 Adverse events and pharmacokinetics data from a phase-I trial in healthy volunteers presented at the American College of Clinical Pharmacology (ACCP-2023)
  • 22 Apr 2023 Long term adverse events data from a phase III trial in Narcolepsy with Cataplexy presented at the 75th Annual Meeting of the American Academy of Neurology 2023 (AAN-2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top